Clinical Lymphoma Myeloma & Leukemia

Clinical Lymphoma Myeloma & Leukemia期刊基本信息

Clinical Lymphoma Myeloma & Leukemia
  • 简称:CL LYMPH MYELOM LEUK
  • 大类:医学
  • 小类:血液学
  • ISSN:2152-2650
  • IF值:2.274
  • 周期:Bimonthly
  • 是否SCI:SCIE
  • 是否OA:No
  • 出版地:UNITED STATES
  • 年文章数:148
  • 审稿速度:较慢,6-12周
  • 平均录用比例:较易

Clinical Lymphoma Myeloma & Leukemia中文简介

《临床淋巴瘤、骨髓瘤和白血病》是一本同行评议的月刊,发表了描述淋巴瘤、骨髓瘤和白血病临床和转化研究各个方面的原始文章。《临床淋巴瘤、骨髓瘤和白血病》专门研究淋巴瘤、骨髓瘤、白血病和相关疾病的检测、诊断、预防和治疗,包括巨球蛋白血症、淀粉样变性和浆细胞贫血。重点是淋巴瘤、骨髓瘤和白血病相关领域的最新科学进展。感兴趣的特定领域包括临床研究和机械方法;药物敏感性和耐药性;基因和反义疗法;病理学、标记物和预后指标;化学预防策略;多模式疗法;以及各种方法的整合。

Clinical Lymphoma Myeloma & Leukemia英文简介

Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

国际期刊推选 论文翻润预审发表!

选择丰富服务快速通过率高一键快速领取私人专属发表方案!

* 请认真填写需求信息,学术顾问24小时内与您取得联系。